FDA approves Medtronic CRT devices for new patient population

April 11, 2014 2:31 PM

4 0

Medtronic announced that the FDA has approved its cardiac resynchronization therapy pacemakers and defibrillators for biventricular pacing in patients with atrioventricular block and left ventricular systolic dysfunction.

According to a company press release, the approval was based on the results of the BLOCK HF trial, which found that patients in those populations assigned biventricular pacing had a 27% relative risk reduction for incidence of the composite study endpoint of heart size, HF-related hospitalization an...

Read more

To category page